Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Oniria Therapeutics logo — A shift in cancer treatment methodology makes a world of dif...

Oniria Therapeutics

A shift in cancer treatment methodology makes a world of difference.

Founded 2021 Spain Spain 16 employees Seed Total: $1.28M Biopharma, Biotechnology +1

General Information

Company Name Oniria Therapeutics
Founded Year 2021
Location Spain Spain +1
Employees 16
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Seed
Social

Get notified when Oniria Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Oniria Therapeutics

Oniria Therapeutics is a biotech startup founded in 2021 with a focus on revolutionizing cancer treatment through precision oncology. The company, based in Spain, has garnered attention for its cutting-edge approach to developing first-in-class drugs in the field of oncology. A recent milestone for Oniria Therapeutics was the successful closure of a €1.28M Seed Round of investment on 11 May 2023. The funding was secured from a diverse group of investors including BStartup, Investigo, Torres Quevedo, Fundacion Botin, Startup Capital Ventures, and ACCIÓ. This financial boost is expected to propel the company's innovative therapies forward. Oniria Therapeutics' flagship product, which allosterically activates TET2, a master epigenetic enzyme, demonstrates its commitment to developing novel targeted strategies to overcome the persistence of dormant tumor cells. As a spin-off from Vall d'Hebron Institute of Oncology (VHIO), the University of Barcelona (UB), and the Catalan Institution for Research and Advanced Studies (ICREA), Oniria Therapeutics has strong roots in renowned research institutions, bolstering its credibility and potential for groundbreaking advancements in cancer treatment. The company's slogan, "A shift in cancer treatment methodology makes a world of difference," encapsulates its mission to bring about transformative change in the field of oncology. With the recent investment and its promising approach to precision oncology, Oniria Therapeutics is poised to make a significant impact in the biopharma and biotechnology industries.

Taxonomy: Oniria Therapeutics, biotech company, precision oncology, drug development, therapy modulation, tumor cell elimination, epigenetic enzyme, cancer treatment, precision medicine, oncology research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 5
Investor
•••• •••• 		11 May 2023

Oniria Therapeutics Alternatives & Competitors

Oniria Therapeutics vs
Aurora Oncology
Aurora Oncology

Pioneering targeted therapeutics to combat non-muscle invasive bladder cancer with precision.

Grant
Biotechnology, Health Care
Oniria Therapeutics vs
Probmet Therapeutics
Probmet Therapeutics Denmark

An oncology therapeutics company developing new targeted treatments for breast cancer brain metastat...

Convertible Note
2 employees
Health Care, Health and Wellness
Oniria Therapeutics vs
AUM Biosciences
AUM Biosciences Singapore

Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse can...

Series A
19 employees
Biotechnology

FAQ About Oniria Therapeutics

A shift in cancer treatment methodology makes a world of difference.
Oniria Therapeutics was founded in 2021.
Oniria Therapeutics is headquartered in Spain.
Oniria Therapeutics operates in the following industries: Biopharma, Biotechnology, Health and Wellness.
Oniria Therapeutics has approximately 16 employees.
Oniria Therapeutics has completed 1 funding round, raising a total of $1.28M. The latest funding stage is Seed.
Top alternatives and competitors to Oniria Therapeutics include Aurora Oncology, Probmet Therapeutics, AUM Biosciences, Acrivon Therapeutics, Inc., Trobix Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oniria Therapeutics and Aurora Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Oniria Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes